UltraSPECT gets FDA nod for cardiac nuc med software

Justine Varieur Cadet | | Health Imaging | Molecular Imaging
The FDA has granted nuclear medicine image reconstruction provider UltraSPECT clearance for its attenuation correction/scatter correction (ACSC) software package.

The new ACSC package is a field upgrade option for wide-beam reconstruction (WBR) cardiac image reconstruction products, which are used in conjunction with gamma camera systems with access to CT-generated attenuation maps, according to the Merrick, N.Y.-based company.

WBR products enhanced from the ACSC upgrade option are Xpress.Cardiac and Xpress3.Cardiac, which enable half-time and quarter-time acquisitions, respectively, according to the Haifa, Israel-based UltraSPECT.


Justine Varieur Cadet

Related Content

Researchers receive grant worth millions to develop portable PET scanner
Why is the US still dependent on foreign medical isotope production?
Downed high-flux reactor could restart sooner than anticipated
Some nuc med departments are already feeling the strain of the isotope shortage
NorthStar opens facility to assist with development and distribution of vital radioisotopes
Lizard saliva could be key to spotting elusive pancreatic tumors

Around the web

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

Cardiovascular Business
Philips, Mayo Clinic using AI to improve cardiac MRI technology

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services.